search
Back to results

Evaluation and Treatment of Heart Disease in Patients Not Participating in Research

Primary Purpose

Arrhythmia, Congenital Heart Defect, Heart Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
inpatient evaluation and management
Sponsored by
National Heart, Lung, and Blood Institute (NHLBI)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional trial for Arrhythmia focused on measuring Training Protocol, Cardiac Diagnosis, Congenital Heart Disease, Acquired Heart Disease, Arrhythmias

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patients with signs or symptoms of heart disease. Patients selected because of either medical or research interest to the Principal Investigator. Patients must not have unstable angina pectoris, unstable course following recent (within one month) myocardial infarction. Must not be in New York Heart Association functional class IV heart failure. A positive pregnancy test will obviate any cardiovascular testing requiring ionizing radiation.

Sites / Locations

  • National Heart, Lung and Blood Institute (NHLBI)

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
November 3, 1999
Last Updated
March 4, 2008
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00001460
Brief Title
Evaluation and Treatment of Heart Disease in Patients Not Participating in Research
Official Title
Evaluation and Therapy of Heart Disease in Patients Not Participating in Research (Teaching Protocol)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2002
Overall Recruitment Status
Completed
Study Start Date
January 1995 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2002 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

5. Study Description

Brief Summary
There is an important need to maintain clinical skills, provide quality training and expertise, and provide an environment that stimulates ideas for clinical research. This study permits inpatient evaluation and management of patients with heart disease who do not qualify to participate in studies currently being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute.
Detailed Description
There is an important need to maintain clinical skills, to ensure adequate training and expertise, and provide an environment that stimulates ideas for clinical research. This protocol permits inpatient evaluation and management of patients with heart disease who do not fulfill criteria for participation in existing Cardiology Branch research protocols.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arrhythmia, Congenital Heart Defect, Heart Disease
Keywords
Training Protocol, Cardiac Diagnosis, Congenital Heart Disease, Acquired Heart Disease, Arrhythmias

7. Study Design

Study Phase
Not Applicable

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
inpatient evaluation and management

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Patients with signs or symptoms of heart disease. Patients selected because of either medical or research interest to the Principal Investigator. Patients must not have unstable angina pectoris, unstable course following recent (within one month) myocardial infarction. Must not be in New York Heart Association functional class IV heart failure. A positive pregnancy test will obviate any cardiovascular testing requiring ionizing radiation.
Facility Information:
Facility Name
National Heart, Lung and Blood Institute (NHLBI)
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation and Treatment of Heart Disease in Patients Not Participating in Research

We'll reach out to this number within 24 hrs